The relevant information included in this section is exactly as published on the website of the National Securities Market Commission (CNMV)

Filter results
Date Title Content PDF
21/10/2021 Liquidity contracts and specialits The Company informs that it has made a deposit in the Liquidity Contract account.  
21/10/2021 On business and financial situation ROVI informs of the delay in the decision on Risperidone ISM® by the FDA
4/10/2021 Liquidity contracts and specialists Liquidity contract: transactions conducted in the third quarter of 2021
1/09/2021 On business and financial situation ROVI informs about the joint statement from Moderna and Takeda on the investigation of suspended lots of the vaccine
29/08/2021 On business and financial situation ROVI informs on the evolution of the investigation of particulate matter having been seen in certain drug product vials of the Moderna COVID-19 vaccine distributed in Japan
26/08/2021 On business and financial situation ROVI informs on the notification of particulate matter having been seen in certain drug product vials of the Moderna's COVID-19 vaccine distributed in Japan
28/07/2021 On business and financial situation ROVI releases the first half 2021 results presentation
28/07/2021 On business and financial situation The company releases the press release related to first half 2021 financial results
16/07/2021 On Corporate Governance ROVI announces the appointment of Juan López-Belmonte Encina as Chairman of the Company  
13/07/2021 Laboratorios Farmacéuticos Rovi regrets the passing of its President Juan López-Belmonte The Company informs about the passing of its President Juan López-Belmonte López

Pages